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1121 MP-125 Evaluation of the Accuracy of a New Semiautomatic 3-D 
Program (PMAP) by Quantifying Right Ventrlcular 
Volume Using RseI-Tlme 3-D Imaging: Studies in an In 
Vitro Model Duplicating Human RV Anatomy 
Lisetfe S.L. Oei. Sebastian T. Schindera, Xiaokui Li, Petre S. Mehwald, Johnny Kuo, 
John Castellucci, Olaf T. von Ramm, Deniz Kececioglu, David J. Sahn, Oregon Hea/th& 
Science University, Portland, Oregon, Universitaetsklinik, Freiburg. Germany, 
Background: We assessed the accuracy of a custom semiautomated 3D analysis pro- 
gram (PMAP, Duke Center for Emerging Cardiovascular Technologies) for measuring dght 
ventdcular volumes (RW) and stroke volumes (SV) acquired from real time 3D (RT3D) 
imaging of static and pulsatile RV cavity models. Methods: We used RT3D (Volumstdcs 
Imaging System) to image 10 static and 5 dynamic elastic RV latex shells cast from human 
hearts in a pulsatile model where actual volume was determined by water displacement. 
Offline measurements were made by manually tracing (Volumetrics program) a family of 8- 
10 dedved B-scans across the imaged volume, or the new PMAP program which semiau- 
tomatically boundary detects 32 deformed circular profiles between the apex, base and 
outflow tract (32 radii [r] emanating from the center of each circle) using all the 3D data 
guided by only 2 or 3 selected traced B-scans. Volume was calculated according to the for- 
mula, ~*B*(r2)*(1/32)*h, where h is height of one slice in the stack of circles. Results: There 
was a strong correlation between the static RVV results of the PMAP pmgrem with the true 
volume. PMAP tended to slightly overestimate the outcome (percent difference: 0.91 ± 
8.71%, r = 0.94) compared to the manual Volumetrics Imaging program (percent differ- 
ence: 0.60 ± 6.91%, r = 0.97). For the dynamic stroke volumes (SV) from the human casts, 
PMAP (percent difference: -4.43 ± 13.98%) versus the Volumetrics manuel tracing pro- 
gram (percent difference: -7.90 ± 14.21%) results were similar. 
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1121MP-126 Molecular Cloning and Characterization of a Potential 
Candidate Gene for Nonsyndromic Atrioventricular 
Septal Defect on 11)31-1p21 
Yopn Zhao, Xianmin Meng, Huiqing Can, Liguo Mi, Yingjie Wei, Choong-Chin Liew, 
Jinfeng Ding, Cardiovascular Institute & Fu Wai Heart Hospital, PUMC & CAMS, Beijing, 
People's Republic of China, Brigham and Women's Hospital, Harvard Medical School, 
Boston, Massachusetts. 
Background: Aifhough atrioventdcular septal defect(AVSD) is commonly associated with 
Down syndrome, its isolated form is not linked to the Down syndrome critical region. 
Genetic studies suggest hat AVSD is a genetically heterogeneous disorder and its isolated 
form differs from syndromic one. Recent efforts have demonstrated that one genetic locus 
for nonsyndromic AVSD maps to chromosome lp31-tp21. While exa~y which gene(s) 
account for nonsyndromic AVSD remains poody understood. The aim of this study was to 
screen for the potential candidate genes for involvement in nonsyndromic AVSD. 
Methods: We applied a bioinformatics-besed approach to analyze the genes located on 
1p31-1p21 against he Genome Database, and their expression level and tissue specificity 
were estimated by the number of expressed sequence tags that were included into the Uni- 
Gene cluster. Biochemical studies were employed for further confirmation. 
Results: Of some dozens of genes, we identified a novel kinase gana located on 1 p31 and 
named it p93 because the 835 amino acid gene product has a predicted Mr of 93 kDa(Gen- 
Bank acc. AFl16826). Sequence analysis demonstrated that p93 may be a distant MAP- 
KKKs member of integdn-linked kinase(ILK) family. Subsequently Northern blot and 76- 
tissue array analysis(Clontech) showed: 1) p93 was expressed in heart, but undetectable 
in any other tissues. 2) Right atdoventdcular p93 mRNA level was higher than the counter- 
part of left. 3) p93 was significantly highly expressed in intarventricular septum and apex of 
heart. Immunohistochemistry revealed that p93 was more highly expressed in the nucleus 
of embryonic ardiac myocytes than in adult. Of note, p93 substantially decreased in myo- 
cardiums of subjects with tetralogy of Fallot comparison with normal ones. In vitro kinase 
analysis showed p93 could autophosphorylate while its dominant negative form(K490R) 
couldn't, which indicated that p93 is a functional kinase. 
Conclusions: p93 is a cardiac-specific and developmentally-regulated kinase, and it may 
be a strong candidate gene involving in nonsyndromic AVSD. 
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1121 MP-127 Spatio-Temporal Descri~ion of the Development of the 
Mouse Cardiac Conduction System Using a cGATA-6 
Gene Enhancer Marker 
Amy L. Juraszek, Angela V. Edwards, Aimee Phelps, John B. Burch, Andy Wsssels, 
Medical University of South Carolina, Charleston, South Carolina, Fox Chase Cancer 
Center, Philadephia, Pennsylvania. 
Background: A fully developed cardiac conduction system is essential for coordinated 
cardiac contraction and unidirectional blood flow through the head. Recently, a cGATA-6/ 
lacZ transgenic mouse model has been generated in which the transgene expression is 
localized to the proximal region of the atdoventricuisr (AV) conduction system {i.e. AV 
node) and the right AV ring bundle (Davis et at., Mech. Dev., Oct 2001) in the postnatal 
heart. 
Methods: [-1.5/+0.8]cGATA-6/lacZ 2.3 kb mouse embryos were obtained at embryonic 
day (ED) 7.5 to ED18. The specimens were stained for lecZ, paraffin embedded, serially 
sectioned, counterstained with nuclear fast red and examined by light microscopy. Digital 
images of the sections were then used to generate three dimensional reconstructions 
using 3D-DOCTOR software (Able Software). 
ResultS: At the paired heart field stage (ED7.5), transgene expression is localized to a 
subpopulation of cells in the lateral portions of the precardiac mesoderm. At ED8.5 the 
expression is found at the AV junction in the myocardium adjacent to the developing 
endocardist cushions. From the AV junction two lacZ positive bends extend towards the 
apex over the anterior and posterior surfaces of the left ventricle. From ED9.5 onward the 
ventricular transgene expression disappears and the lacZ positive region becomes more 
restricted to the right AV junction including the region of the developing AV node. As the 
atrial and ventricuiar myocardium become separated by the fusion of sulcus and cushion 
derived tissues (ED14 and beyond), the transgene expression becomes incorporated 
into the right atrial myocardium along the lateral and posterior rim of the tricuspid valve 
annutus and in the area of the developing AV node. 
Conclusion: The cGATA-6/lacZ transgenic onstruct studied identifies a distinct subpop- 
ulation of cells in the precardiac mesodarm at eady stages of development. At advanced 
stages of development he cGATA-6/lacZ expression is found in the proximal portion of 
the AV conduction system and dght AV ring bundle. This cGATA6 construct appears to 
be the earliest reported marker for the developing conduction system. Further cell fate 
studies using a cre°lox approach are in progress. 
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1121 MP-128 Shortened Outf low Tract Leads to Altered Cardiac 
Looping After Neural Crest Ablation 
Taiat Mesud Yel~uz. Karen L. Waldo, Donna H. Kumiski, Harriett A. Stadt, Raymond R. 
Wolfe, Linda Leatherbury, Margaret L. Kirby, Duke University Medical Center, Durham, 
North Carolina. 
Background - Congenital conotruncal malformations are associated with the highest mor- 
tality dsk in utero and after postnatal surgical repair, and frequently involve dextroposed 
aorta. The pathogenesis of daxtroposed aorta is not known but is thought o be due to 
abnormal looping and/or wedging of the outflow tract during early heart development. 
The elongation of the outflow limb of the cardiac tube is a critical step in the normal pro. 
cess of looping insofar as it provides required extra material to lengthen the heart tube. 
We examined cardiac morphology in an experimental model of dextroposad aorta to 
determine whether altered lengthening of the outflow limb plays a role in dextroposition of 
the aorta. 
Methods and Results - Hearts were examined in normal chick embryos and compared 
with those in cardiac neural crest-ablated embryos using time-lapse vldsophotography, 
scanning electron microscopy and histological sectioning (collected embryos: n=118; 
analyzed embryos: n=88). We found that in neural crest-ablated embryos the inflow and 
outflow limbs of the looped cardiac tube were malpositioned with respect to each other, 
the inner curvature of the looped tube was diminished, and the outflow limb straighter 
and displaced cranially in a manner consistent with diminished length. Furthermore, we 
found that movement of cells from the secondary heart field into the myocardium of the 
outflow tract was significantly less as shown by a paucity of HNK-1 positive cells in the 
secondary heart field and outflow myocardium. 
Conclusions'- The data are consistent with previous experiments from many labs show- 
ing that normal ldoping and wedging are essential for normal alignment of the aorta with 
the left ventricle. Our results show that addition of myocerdium to the outflow tract is nec- 
essary for normal looping and wedging to occur at all, and indicates for the first time that 
the shortened outflow limb is a result of failure of the outflow tract to lengthen by addition 
of myocardial cells from the secondary heart field. 
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1121MP-129 Increased Vascular Endcthellal Growth Factor In 
Patients With Cyanotic Congenital Heart Disease May 
Not be Normalized After Fontan l~/pe Operation 
K~nii Soda. Masahiko Matsumura, Setsuko Miyenishi, Temi Hospital, Tenrl, Japan, Tenrl 
Medical Research Institute, Tenrl, Japan. 
BACKGROUND: There is no data available concerning the change of vascular endothe- 
lial growth factor (VEGF) in patients with cyanotic congenital heart disease (C-CHD). 
PURPOSE: To determine the change of serum concentration of VEGF In patients with C- 
CHD. METHODS: Subjects were divided into 2 groups; A(age 1 - 20 years) and B {age > 
20 years). Group A was subdivided into 4 groups; AI, 23 patients with uncorrected C- 
CHD; A2, 13 controls; A3, 8 patients who had C-CHD and were treated with bi-ventdcular 
